Research Article
Erythropoietin Resistance Development in Hemodialysis Patients: The Role of Oxidative Stress
Table 4
Biochemical profiles of patients according to long-acting EPO (darbepoetin-α) resistance.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Values are shown as , except for FOL and VitB12, where data were not normally distributed and shown as median (interquartile range). ERI, erythropoietin resistance index; Hb, hemoglobin; Hct, hematocrit, MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; FOL, serum folate concentration; VitB12, serum vitamin B12 concentration; Fe, serum iron concentration; TSAT, transferrin saturation; FER, serum ferritin concentration; CRP, serum C-reactive protein concentration; TP, serum total protein concentration, ALB, serum albumin concentration; PALB, serum prealbumin concentration; TRSF, serum transferrin concentration; UA, serum uric acid concentration; BMI, body mass index; nPCR, normalized protein catabolic rate; IDWG, interdialytic weight gain; VitD, serum vitamin D concentration; iPTH, serum intact parathormone concentration; Kt/V, hemodialysis adequacy index; spKt/V, single-pool index of hemodialysis adequacy; URR, urea reduction ratio; MMDI, mean monthly dose of i.v. iron. |